cystamine has been researched along with Leprosy in 1 studies
Leprosy: A chronic granulomatous infection caused by MYCOBACTERIUM LEPRAE. The granulomatous lesions are manifested in the skin, the mucous membranes, and the peripheral nerves. Two polar or principal types are lepromatous and tuberculoid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This reports a long-term follow-up study on clinical effects of ofloxacin (OFLX)-combined therapy to 14 leprosy patients with various types and stages." | 7.74 | [Long-term follow-up of ofloxacin-combined therapy for leprosy patients]. ( Ishikawa, M; Ozaki, M, 2007) |
| "This reports a long-term follow-up study on clinical effects of ofloxacin (OFLX)-combined therapy to 14 leprosy patients with various types and stages." | 3.74 | [Long-term follow-up of ofloxacin-combined therapy for leprosy patients]. ( Ishikawa, M; Ozaki, M, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ozaki, M | 1 |
| Ishikawa, M | 1 |
1 other study available for cystamine and Leprosy
| Article | Year |
|---|---|
[Long-term follow-up of ofloxacin-combined therapy for leprosy patients].
Topics: Aged; Anti-Bacterial Agents; Clofazimine; Cystamine; Drug Therapy, Combination; Follow-Up Studies; H | 2007 |